EVALUATION OF THE EFFICACY, SAFETY, AND TOLERABILITY OF EZETIMIBE IN PRIMARY HYPERCHOLESTEROLAEMIA: A POOLED ANALYSIS FROM TWO CONTROLLED PHASE III CLINICAL STUDIES von Knopp, RH, Dujovne, CA, Le Beaut, A, Lipka, LJ, Suresh, R, Veltri, EP

Volltext

Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: pooled analysis of two phase II studies von Bays, Harold E, Moore, Paul B, Drehobl, Margaret A, Rosenblatt, Sidney, Toth, Phillip D, Dujovne, Carlos A, Knopp, Robert H, Lipka, Leslie J, LeBeaut, Alexandre P, Yang, Bo, Mellars, Lillian E, Cuffie-Jackson, Cynthia, Veltri, Enrico P

Volltext

Drug interactions of lipid-altering drugs von BAYS, H. E, DUJOVNE, C. A

Volltext

Safety and efficacy of ezetimibe monotherapy in 1624 primary hypercholesterolaemic patients for up to 2 years von Dujovne, C. A., Suresh, R., McCrary Sisk, C., Maccubbin, D., Strony, J., Veltri, E.

Volltext

Effect of atorvastatin on hemorheologic-hemostatic parameters and serum fibrinogen levels in hyperlipidemic patients von Dujovne, Carlos A, Harris, William S, Altman, Raul, Overhiser, Ron W, Black, Donald M

Volltext

The Efficacy and Six-Week Tolerability of Simvastatin 80 and 160 mg/Day von Davidson, Michael H., Stein, Evan A., Dujovne, Carlos A., Hunninghake, Donald B., Weiss, Stuart R., Knopp, Robert H., Illingworth, D.Roger, Mitchel, Yale B., Melino, Michael R., Zupkis, Robert V., Dobrinska, Michael R., Amin, Raju D., Tobert, Jonathan A.

Volltext

Comparison of effects of simvastatin versus atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I levels von Kastelein, John J.P, Isaacsohn, Jonathan L, Ose, Leiv, Hunninghake, Donald B, Frohlich, Jiri, Davidson, Michael H, Habib, Rafik, Dujovne, Carlos A, Crouse, John R, Liu, Minzhi, Melino, Michael R, O’Grady, Laura, Mercuri, Michele, Mitchel, Yale B

Volltext

efficacy of intensive dietary therapy alone or combined with lovastatin in outpatients with hypercholesterolemia von Hunninghake, D.B, Stein, E.A, Dujovne, C.A, Harris, W.S, Feldman, E.B, Miller, V.T, Tobert, J.A, Laskarzewski, P.M, Quiter, E, Held, J

Volltext

Effects of sibutramine on body weight and serum lipids: A double-blind, randomized, placebo-controlled study in 322 overweight and obese patients with dyslipidemia von Dujovne, Carlos A., Zavoral, James H., Rowe, Everton, Mendel, Carl M.

Volltext

Efficacy and short-term safety of a new ACAT inhibitor, avasimibe, on lipids, lipoproteins, and apolipoproteins, in patients with combined hyperlipidemia von Insull, William, Koren, Michael, Davignon, Jean, Sprecher, Dennis, Schrott, Helmut, Keilson, Leonard M, Brown, Alan S, Dujovne, Carlos A, Davidson, Michael H, McLain, Richard, Heinonen, Therese

Volltext

New lipid lowering drugs and new effects of old drugs von Dujovne, C A

Volltext

Middle-aged men at high risk of cardiovascular disease: the west of scotland coronary prevention study von Dujovne, Carlos A

Volltext

The clinical therapeutic implications of the Scandinavian Simvastatin Survival Study von Dujovne, Carlos A.

Volltext

Long-term blood cholesterol–lowering effects of a dietary fiber supplement von Knopp, Robert H, Superko, H.Robert, Davidson, Michael, Insull, William, Dujovne, Carlos A, Kwiterovich, Peter O, Zavoral, James H, Graham, Kevin, O’Connor, Robert R, Edelman, David A

Volltext

Colesevelam HCl: a non-systemic lipid-altering drug von Bays, Harold, Dujovne, Carlos

Volltext

Dual hepatic metabolism of cerivastatin--clarifications von Guyton, J R, Dujovne, C A, Illingworth, D R

Volltext

New pharmacological agents under clinical investigation for treating disorders of lipoprotein regulation leading to atherosclerosis von Gallup, Elizabeth, Dujovne, Carlos

Volltext

Efficacy and safety of Simvastatin 80 mg/day in hypercholesterolemic patients von Stein, Evan A, Davidson, Michael H, Dobs, Adrian S, Schrott, Helmut, Dujovne, Carlos A, Bays, Harold, Weiss, Stuart R, Melino, Michael R, Stepanavage, Michael E, Mitchel, Yale B

Volltext

Probucol von Pfuetze, K D, Dujovne, C A

Volltext

Efficacy and Safety of Cerivastatin 0.8 mg in Patients with Hypercholesterolaemia: The Pivotal Placebo-Controlled Clinical Trial von Insull, W, Isaacsohn, J, Kwiterovich, P, Ma, P, Brazg, R, Dujovne, C, Shan, M, Shugrue-Crowley, E, Ripa, S, Tota, R

Volltext